A detailed history of Norman Fields, Gottscho Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Norman Fields, Gottscho Capital Management, LLC holds 4,215 shares of ABBV stock, worth $690,585. This represents 0.29% of its overall portfolio holdings.

Number of Shares
4,215
Previous 4,248 0.78%
Holding current value
$690,585
Previous $658,000 16.72%
% of portfolio
0.29%
Previous 0.26%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

SELL
$159.82 - $182.1 $5,274 - $6,009
-33 Reduced 0.78%
4,215 $768,000
Q2 2023

Jul 07, 2023

SELL
$132.51 - $164.9 $98,057 - $122,026
-740 Reduced 14.84%
4,248 $572,000
Q3 2021

Oct 12, 2021

SELL
$106.4 - $120.78 $10,640 - $12,078
-100 Reduced 1.97%
4,988 $538,000
Q2 2021

Jul 12, 2021

SELL
$105.21 - $117.21 $12,625 - $14,065
-120 Reduced 2.3%
5,088 $573,000
Q1 2021

Apr 13, 2021

SELL
$102.3 - $112.62 $19,130 - $21,059
-187 Reduced 3.47%
5,208 $564,000
Q4 2020

Jan 07, 2021

SELL
$80.49 - $108.67 $6,841 - $9,236
-85 Reduced 1.55%
5,395 $578,000
Q3 2020

Oct 09, 2020

SELL
$85.91 - $100.83 $88,057 - $103,350
-1,025 Reduced 15.76%
5,480 $480,000
Q2 2020

Jul 14, 2020

SELL
$73.37 - $98.18 $41,820 - $55,962
-570 Reduced 8.06%
6,505 $639,000
Q1 2020

Apr 13, 2020

SELL
$64.5 - $97.79 $370,230 - $561,314
-5,740 Reduced 44.79%
7,075 $539,000
Q4 2019

Jan 13, 2020

SELL
$72.13 - $90.25 $4,688 - $5,866
-65 Reduced 0.5%
12,815 $1.14 Million
Q3 2019

Oct 09, 2019

SELL
$62.98 - $75.72 $15,115 - $18,172
-240 Reduced 1.83%
12,880 $975,000
Q3 2017

Oct 02, 2017

BUY
$69.85 - $89.22 $916,431 - $1.17 Million
13,120
13,120 $1.17 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Norman Fields, Gottscho Capital Management, LLC Portfolio

Follow Norman Fields, Gottscho Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norman Fields, Gottscho Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norman Fields, Gottscho Capital Management, LLC with notifications on news.